Bagdade J D, Yee E, Wilson D E
J Lab Clin Med. 1978 Jan;91(1):176-86.
To determine whether hypertriglyceridemia in chronic renal failure resulted from altered production and/or removal, Sprague-Dawley rats in which chronic uremia had been induced by five-sixths nephrectomy were studied. In this model, basal plasma TG levels were higher than in controls (uremic 141 +/- 52 mg/100 ml; control 83 +/- 25; mean +/- SD; p less than 0.001) at 1 month after nephrectomy and remained significantly elevated throughout the 10-week duration of study. In the uremic animals hepatic TGSR's (Triton) were not increased (uremic 0.56 +/- 0.11 mg/min; control 0.63 +/- 0.13) and AcCoAc, the rate-limiting enzyme in hepatic lipogenesis, was significantly reduced (control 24.5 +/- 3.8 nM/min/mg protein; uremic 18.2 +/- 1.1; p less than 0.005). The TG removal system--heparin-elutable LPL activities--was similar in control and uremic animals in heart, diaphragm, and adipose tissue. However, serum from both acute and chronically uremic rats lowered adipose LPL activity (P less than 0.01). These observations suggest that in uremia (1) TG production is not increased and (2) the clearance of TG-rich lipoprotein from the circulation is reduced because of a functional impairment in LPL.
为了确定慢性肾衰竭中的高甘油三酯血症是由生成改变和/或清除改变所致,我们对通过六分之五肾切除诱导慢性尿毒症的Sprague-Dawley大鼠进行了研究。在这个模型中,肾切除术后1个月时,基础血浆TG水平高于对照组(尿毒症组141±52mg/100ml;对照组83±25;均值±标准差;p<0.001),并且在整个10周的研究期间一直显著升高。在尿毒症动物中,肝脏TGSR's(Triton)没有增加(尿毒症组0.56±0.11mg/min;对照组0.63±0.13),并且肝脏脂肪生成中的限速酶乙酰乙酸辅酶A显著降低(对照组24.5±3.8nM/min/mg蛋白;尿毒症组18.2±1.1;p<0.005)。TG清除系统——肝素可洗脱的LPL活性——在对照组和尿毒症组动物的心脏、膈肌和脂肪组织中相似。然而,急性和慢性尿毒症大鼠的血清均降低了脂肪组织的LPL活性(P<0.01)。这些观察结果表明,在尿毒症中:(1)TG生成没有增加;(2)由于LPL功能受损,富含TG的脂蛋白从循环中的清除减少。